Clinicians report that early AKT inhibition side effects are manageable, allowing four out of five patients to maintain ...

USPTO Allows Claims Covering Topical Metformin Eye-Drop Therapy for Retinal Degeneration, Including Age-Related Macular DegenerationPalm Beach ...

GLP-1 receptor agonists were associated with a higher risk for eye complications vs. other diabetes medications, two studies ...

In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

Metformin can cause stomach upset, but taking it with food, increasing doses gradually, and considering extended-release ...

Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Could aging be optional? According to renowned biological aging ...

It's great when nutrition and lifestyle offer a viable alternative to medication, but the idea that it’s an easy trade isn’t ...

Metformin does not significantly reduce the risk for long COVID at 6 months in low-risk adults with high baseline immunity to the virus.

As summer temperatures climb, so do the risks of heat-related illnesses, particularly for those who take certain medications, ...

If you have type 2 diabetes, your health care provider may recommend metformin or Mounjaro to help manage your blood sugar.